Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer

被引:20
|
作者
Luiten, Jacky D. [1 ,4 ]
Voogd, Adri C. [2 ,3 ]
Luiten, Ernest J. T. [4 ]
Duijm, Lucien E. M. [5 ,6 ]
机构
[1] Erasmus Univ, Univ Med Ctr, Fac Med & Hlth Sci, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands
[2] Maastricht Univ, Fac Hlth Med & Life Sci, Res Inst GROW, Dept Epidemiol, Utrechtse Singel 40, NL-6229 ER Maastricht, Netherlands
[3] Netherlands Comprehens Canc Org, Dept Res, Godebaldkwartier 419, NL-3511 DT Utrecht, Netherlands
[4] Amphia Hosp, Dept Breast Surg, Molengracht 21, NL-4818 CK Breda, Netherlands
[5] Canisius Wilhelmina Hosp, Dept Radiol, Weg Door Jonkerbos 100, NL-6532 SZ Nijmegen, Netherlands
[6] Dutch Reference Ctr Screening, Wijchenseweg 101, NL-6538 SW Nijmegen, Netherlands
关键词
Breast cancer screening; Ductal carcinoma in situ; Invasive breast cancer; Tumour grade; MAMMOGRAPHY; NETHERLANDS; PROGRAM; OVERDIAGNOSIS; OVERTREATMENT; WOMEN;
D O I
10.1007/s10549-017-4412-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a biennial screening mammography programme, we analysed the trends in incidence of screen-detected DCIS and invasive breast cancers in the era of screen-film mammography (SFM) screening, the period of the transition to full-field digital mammography (FFDM) screening and the period of FFDM screening. We also investigated a possible association between the incidence and grading of screen-detected DCIS and invasive breast cancer. In the southern part of the Netherlands, FFDM screening gradually replaced SFM screening between May 2009 and April 2010. We included a consecutive series of 484, 422 screens obtained between July 2005 and July 2015 and divided these screens into three groups; SFM-only cohort, transition cohort and FFDM-only cohort. A total of 3059 referred women were diagnosed with DCIS (n = 623) or invasive breast cancer (n = 2436). The majority of DCIS were high-grade (48.2%), whereas the majority of the invasive breast cancers were low-grade (45.4%) or intermediate-grade (41.6%). The cancer detection rate (CDR) per 1000 screened women showed the same distribution by grade in both groups. The transition to FFDM was characterised by an increased overall detection rate of invasive cancers. Screening mammography detects mostly high-grade DCIS and low- or intermediate-grade invasive cancers. The grade distribution as well as the CDR in the years after the introduction of FFDM remained stable compared to the era of SFM screening. By diagnosing and treating high-grade DCIS, which otherwise may develop into high-grade invasive carcinoma, our findings provide new evidence for the beneficial value of screening mammography programmes.
引用
收藏
页码:307 / 314
页数:8
相关论文
共 50 条
  • [41] Molecular subtypes of screen-detected breast cancer
    Gelareh Farshid
    David Walters
    Breast Cancer Research and Treatment, 2018, 172 : 191 - 199
  • [42] Molecular subtypes of screen-detected breast cancer
    Farshid, Gelareh
    Walters, David
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (01) : 191 - 199
  • [43] Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands between 1989 and 2021: Time trends and the association with tumour grade
    O'Leary, R.
    Duijm, L.
    Boersma, L.
    van der Sangen, M.
    de Munck, L.
    Wesseling, J.
    Schipper, R. J.
    Voogd, A.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 15 - 16
  • [44] Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
    R R Millis
    S E Pinder
    K Ryder
    R Howitt
    S R Lakhani
    British Journal of Cancer, 2004, 90 : 1538 - 1542
  • [45] Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
    Millis, RR
    Pinder, SE
    Ryder, K
    Howitt, R
    Lakhani, SR
    BRITISH JOURNAL OF CANCER, 2004, 90 (08) : 1538 - 1542
  • [46] The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease
    Duffy, SW
    Tabar, L
    Vitak, B
    Day, NE
    Smith, RA
    Chen, HHT
    Yen, MFA
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) : 1755 - 1760
  • [47] Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?
    Evans, AJ
    Pinder, SE
    Ellis, IO
    Wilson, ARM
    JOURNAL OF MEDICAL SCREENING, 2001, 8 (03) : 149 - 151
  • [48] Patterns of care: radiotherapy after breast conserving surgery and the use of endocrine therapy for screen-detected ductal carcinoma in situ (DCIS) in the UK
    Clements, Karen
    Dodwell, David
    Sawyer, Elinor
    Cutress, Ramsey
    Sharma, Nisha
    Shaaban, Abeer
    Thompson, Alastair
    CANCER RESEARCH, 2024, 84 (09)
  • [49] Invasive breast cancer following ductal and lobular carcinoma in situ of the breast
    Levi, F
    Randimbison, L
    Te, VC
    La Vecchia, C
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (05) : 820 - 823
  • [50] Comparison Between Screen-detected Invasive Breast Cancer and Symptomatic Breast Cancer According to Immunohistochemical Intrinsic Subtypes
    Kobayashi, N.
    Ushimado, K.
    Hikichi, M.
    Miyajima, S.
    Utsumi, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S85 - S85